Literature DB >> 7673979

The RG2 rat glioma model.

A T Aas1, A Brun, C Blennow, S Strömblad, L G Salford.   

Abstract

The ethylnitrosourea-induced cell line RG2 grows very well in infinite cell culture in vitro, and provides a simple, reproducible glioma model when inoculated into the brains of syngeneic Fischer 344 rats. We have used this tumor model in a series of therapy studies. We here report our experiences of the untreated (= tumor bearing control) animals, e.g. in terms of the techniques employed and also the growth, histology and effects upon the blood-brain barrier of the tumors. Weight loss as a measure of systemic effects during tumor development is also described. The RG2 model has considerable potential as a suitable tool for experimental neuro-oncology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673979     DOI: 10.1007/bf01059948

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  13 in total

1.  RG2 glioma growth in rat cerebellum after subdural implantation.

Authors:  S Krajewski; J C Kiwit; W Wechsler
Journal:  J Neurosurg       Date:  1986-08       Impact factor: 5.115

2.  A new brain tumour therapy combining bleomycin with in vivo electropermeabilization.

Authors:  L G Salford; B R Persson; A Brun; C P Ceberg; P C Kongstad; L M Mir
Journal:  Biochem Biophys Res Commun       Date:  1993-07-30       Impact factor: 3.575

3.  Permeability of different experimental brain tumor models to horseradish peroxidase.

Authors:  D R Groothuis; J M Fischer; G Lapin; D D Bigner; N A Vick
Journal:  J Neuropathol Exp Neurol       Date:  1982-03       Impact factor: 3.685

4.  Regional measurements of blood flow in experimental RG-2 rat gliomas.

Authors:  D R Groothuis; J F Pasternak; J M Fischer; R G Blasberg; D D Bigner; N A Vick
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

5.  Regional measurements of blood-to-tissue transport in experimental RG-2 rat gliomas.

Authors:  D R Groothuis; J M Fischer; J F Pasternak; R G Blasberg; N A Vick; D D Bigner
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

Review 6.  Chemical induction of brain tumors in rats by nitrosoureas: molecular biology and neuropathology.

Authors:  T Bilzer; G Reifenberger; W Wechsler
Journal:  Neurotoxicol Teratol       Date:  1989 Nov-Dec       Impact factor: 3.763

7.  Chlorpromazine in combination with nitrosourea inhibits experimental glioma growth.

Authors:  A T Aas; A Brun; R W Pero; L G Salford
Journal:  Br J Neurosurg       Date:  1994       Impact factor: 1.596

8.  Reduced formation of high molecular weight DNA in murine gliomas treated with nitrosourea and chlorpromazine.

Authors:  A T Aas; L G Salford; S Lönn; U Lönn
Journal:  Anticancer Res       Date:  1994 May-Jun       Impact factor: 2.480

9.  Regional metabolism of experimental brain tumors.

Authors:  K A Hossmann; G Mies; W Paschen; L Szabo; E Dolan; W Wechsler
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Growth inhibition of rat glioma cells in vitro and in vivo by aspirin.

Authors:  A T Aas; T I Tønnessen; A Brun; L G Salford
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

View more
  17 in total

1.  Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.

Authors:  P F Behrens; H Langemann; R Strohschein; J Draeger; J Hennig
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

2.  Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.

Authors:  Karsten Geletneky; Irina Kiprianova; Ali Ayache; Regina Koch; Marta Herrero Y Calle; Laurent Deleu; Clemens Sommer; Nadja Thomas; Jean Rommelaere; Jörg R Schlehofer
Journal:  Neuro Oncol       Date:  2010-03-18       Impact factor: 12.300

3.  Lentiviral-induced high-grade gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H.

Authors:  John Lynes; Mia Wibowo; Carl Koschmann; Gregory J Baker; Vandana Saxena; A K M G Muhammad; Niyati Bondale; Julia Klein; Hikmat Assi; Andrew P Lieberman; Maria G Castro; Pedro R Lowenstein
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

4.  Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.

Authors:  H M Smilowitz; D D Joel; D N Slatkin; P L Micca; M M Nawrocky; K Youngs; W Tu; J A Coderre
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

5.  The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma.

Authors:  Andreas Jordan; Regina Scholz; Klaus Maier-Hauff; Frank K H van Landeghem; Norbert Waldoefner; Ulf Teichgraeber; Jens Pinkernelle; Harald Bruhn; Fabian Neumann; Burghard Thiesen; Andreas von Deimling; Roland Felix
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

Review 6.  Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.

Authors:  R F Barth
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

7.  Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.

Authors:  Moira C Ferrier; Hemant Sarin; Steve H Fung; Bawarjan Schatlo; Ryszard M Pluta; Sandeep N Gupta; Peter L Choyke; Edward H Oldfield; David Thomasson; John A Butman
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.

Authors:  Alice Gaudin; Eric Song; Amanda R King; Jennifer K Saucier-Sawyer; Ranjit Bindra; Didier Desmaële; Patrick Couvreur; W Mark Saltzman
Journal:  Biomaterials       Date:  2016-08-04       Impact factor: 12.479

9.  Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.

Authors:  Lindsay H Levkoff; Gregory P Marshall; Heather H Ross; Maria Caldeira; Brent A Reynolds; Meryem Cakiroglu; Christopher L Mariani; Wolfgang J Streit; Eric D Laywell
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

10.  Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Kyle R Brimacombe; Steve H Fung; Alioscka A Sousa; Sungyoung Auh; Colin M Wilson; Kamal Sharma; Maria A Aronova; Richard D Leapman; Gary L Griffiths; Matthew D Hall
Journal:  J Transl Med       Date:  2008-12-18       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.